20.07.2023 - LOS ALTOS, Calif., July 20, 2023 (GLOBE NEWSWIRE) - Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the “Company” or “Unicycive”), today announced that ...